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BASAL, lipopolysaccharide (LPS) and silica-stimulated
prostaglandin  (PG)  production  were  compared
between  peripheral  blood  mononuclear  cells
(PBMNC) from UC patients and healthy subjects (HS).
Basal and LPS-stimulated PBMNC PGI2, but not PGE2,
production  was  greater  in  UC.  LPS  stimulated  both
PGE2 and PGI2 by PBMNC from HS and UC patients.
Silica stimulated production of both PGs by cells from
HS  but  only  PGE2 by  cells  from  UC  patients.  The
differences in responses to silica and LPS may result
from  differences  in  activation  of  NFk B  or,  alterna-
tively, prior sensitisation to one of these agents. That
PBMNC PGE2 production is not increased in UC, as it
is in Crohn’s disease, suggests that there are differ-
ences  in  PBMNC  behaviour  between  these  two
diseases.
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Introduction
The accumulation of leukocytes that produce prosta-
glandins (PG), specifically mononu-clear cells (MNC),
within  the  inflamed  mucosa  is  closely  associated
with, and responsible for, the elevated levels of PGs
reported in luminal contents and mucosal incubations
in inflammatory bowel disease (IBD). However, there
have been relatively few studies on MNC PG produc-
tion in IBD, and only one of peripheral blood MNC
(PBMNC) PG production in UC.1 In addition, different
stimuli have different effects on PG production and
previous studies have either measured unstimulated
production  or  used  only  lipopolysaccharide  (LPS).
There  have  been  no  previous  studies  into  the
differences in MNC cell responses to various stimuli
in IBD.
Thus  the  aim  of  this  study  was  to  investigate
whether  the  production  of  both  stimulated  and
unstimulated PG production by peripheral blood MN
cells (PBMNC) is increased in UC in response to two
different stimuli, namely silica and LPS. PG produc-
tion was measured as PGE2 and PGI2, as differential
production of cyclo-oxygenase products by different
stimuli is well recognised.
Materials and methods
PBMNC were separated from 21 UC patients (14 male,
median age 36  years, range 22–84) and 14 healthy
subjects  (controls;  10  male,  median  age  30  years,
range 21–41).2 Healthy subjects (HS) had not taken
any medication, including non-steroidal agents, for at
least  five  days  prior.  Of  the  21  patients:  13  had
inactive  disease;3 two  [inactive]  were  receiving  no
treatment; 10 were receiving sulphasalazine, and 12
corticosteroids. The  study  was  approved  by  the  St
Thomas’  Ethical  Committee  and  all  patients  gave
informed written consent.
Heparinised,  peripheral  venous  blood  samples
(40ml)  were  centrifuged  at  200g  for  10min. The
plasma was then discarded and the cells resuspended
to the original volume in Dulbecco’s calcium, magne-
sium-free phosphate buffered saline and RPMI–1640
tissue culture medium, 1:1 (v/v) mixture with addi-
tives.2 Tenml  was  then  layered  onto  8ml  Ficoll
Hypaque and centrifuged at 400g for 30min at room
temperature.
PBMNC were  aspirated, washed  three  times  and
resuspended in 15ml of the same solution. Aliquots of
cells were taken for total cell counts, viability (trypan
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tion (non-specific esterase staining). Basal (unstimu-
lated), LPS (10mg/ml) – stimulated or silica (Gasel 23,
Crossfields Chemicals, Warrington, Cheshire) – stimu-
lated incubations of 1 ´ 106 viable PBMNCml–1, were
performed in 50mmol l–1 2-mercaptoethanol supple-
mented RPMI–1640 medium, at 37°C, in a humidified
atmosphere of 5% CO2 in  air,  for  24h. Incubations
were centrifuged at 350 ´ g for 7min at 4°C and cell-
free supernatants  stored at  –20°C for less than two
months.
Samples  were  assayed,  in  duplicate,  by  radio-
immunoassay.2 Measures  of  quality  control  were
within  previously  determined  values  and  complete
inhibition  of  PG  production  by  indomethacin  con-
firmed assay specificity.
The  Wilcoxon  2-sample  test  for  paired  data  was
used to test whether stimulation has an effect on PG
production, and the Mann-Whitney test for unpaired
data used for comparisons between groups.
Results
Basal PGI2 production by PBMNC from UC patients
was greater than that by cells from HS. LPS stimula-
tion  increased  both  PGE2 and  PGI2 production  by
PBMNC  from  patients  with  UC  and  HS  (Table  1).
Stimulation with silica increased PGE2 production by
cells from  patients  with  both UC  and  HS  but  only
stimulated PGI2 production by cells from HS. There
was  no  difference  in  basal  PGE2 production  by
PBMNC from patients with UC and HS.
Stimulated  PG  production  was  independent  of
basal production, with no correlation between basal
and either LPS-, or silica-stimulated production in UC
patients or HS. Thus PG production in  response to
stimulation alone, derived by subtracting basal from
stimulated PG levels, was compared, thereby possibly
eliminating any effects of stimulation arising from or
due to  preparation techniques. After  correcting for
basal production, there was no difference in either
LPS- or silica-stimulated PGE2 production between HS
and UC patients, or in  LPS-stimulated PGI2 produc-
tion. However, PBMNC from UC patients produced
significantly less silica-stimulated PGI2 than did cells
from HS.
No effects of disease activity, or either steroid or
sulphasalazine therapy, on PG production were dis-
cernible. There were no differences in viability, purity
or percentage monocyte composition of the PBMNC
preparations  from  UC  patients  and  HS;  thus,  in
agreement with previous studies, any differences do
not arise from different numbers of monocytes in the
incubations.
Discussion
PBMNC  from  patients  with  UC  had  an  increased
ability to synthesise PGI2 but not PGE2. Unlike cells
from HS, PBMNC from UC patients failed to increase
PGI2 production in response to silica. This response
appeared to be specific to PGI2 as cells from both UC
patients  and  HS  increased  PGE2 production  in
response to silica. The previous lack of detection of
PGI2 production by  PBMNC in UC,1 whereas these
cells  have  been  widely  reported  to  produce  this
eicosanoid, may result from differences in incubation
or preparation techniques, or different assay sensitiv-
ities, all of which have been reported to influence the
detection of PGs.
In agreement with previous studies of peripheral
blood and intestinal MN cells, PBMNC production of
PGE2 by  was  not  increased  in  UC.1,4 Although,
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Table 1. PG production in response to stimulation with lipopolysaccharide (LPS) and silica by
PBMNC from patients with ulcerative colitis (UC), compared with that by cells from healthy
subjects (HS), with and without correction for basal production. Data expressed as medians and
lower to upper quartiles
Prostaglandin pg/10
6 PBMNC; median (lower–upper quartiles)
Basal or stimulated HS UC
PGE2 Basal 380 (268–458) 439 (324–557)
LPS
e652 (497–888)
e745 (563–884)
LPS – basal 260 (182–452) 326 (141–390)
Silica
e685 (512–793)
c702 (524–849)
Silica – basal 318 (129–398) 166 (58–278)
PGI2 Basal 110 (63–132) **156 (122–183)
LPS
c137 (106–182)
e183 (148–223)
LPS – basal 27 (12–38) 44 (16–82)
Silica
c150 (108–192) 161 (150–183)
Silica – basal 43 (17–92) *13 (–22–37)
Lipopolysaccharide  (LPS) or silica stimulation vs none (basal): c = p < 0.005, d = p < 0.002, e = p < 0.001.
Ulcerative colitis (UC) vs healthy subjects (HS): * = p < 0.05, ** = p < 0.005. PGI2 measured as 6KF1a.previous studies have identified effects of sulphasala-
zine on PBMNC PG production in vitro, these were
not  confirmed  in  patients,  possibly  owing  to  con-
founding  factors  of  disease  activity  and  other
treatments.2
The different effects of the two stimulants upon the
cyclo-oxygenase pathway may arise from the different
effects of LPS and silica on PBMNC NFkB activation,6,7
involved  in  regulation  of  cyclooxygenase  activity.
Increased levels of NFkB activation occur in MN cells
in the bowel.5 Alternatively, silica has been implicated
in  the  pathogenesis  of  IBD,8 while  there could  be
increased passage of endotoxins across the inflamed
bowel.  Moreover,  previous  studies  in  animals  have
shown that prior exposure in vivo to such stimulants
can  effect  responses  on  cells  in  vitro.9,10 The
response of PBMNC to silica is selectively altered in
UC, which may indicate changes in cellular activation
of  MNC,  while  the  differences  in  PG  production
between  CD  and  UC  may  indicate  some  intrinsic
differences in MNC activity in the two IBDs.
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